New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
aTyr Pharma, Inc. (ATYR) vs Cellectar Biosciences, Inc. (CLRB)
- aTyr Pharma, Inc. ATYR 3.82 +3.52%
- Cellectar Biosciences, Inc. CLRB 0.80 −9.09%
aTyr Pharma, Inc. and Cellectar Biosciences, Inc. are both Biotechnology companies. aTyr Pharma, Inc. and Cellectar Biosciences, Inc. are of similar size ($9.0M and $8.9M). Cellectar Biosciences, Inc. has the higher net margin (0.00% vs −155.2%) and the higher return on invested capital (0.00% vs 0.00%). Across the 13 metrics below, Cellectar Biosciences, Inc. leads on 10 and aTyr Pharma, Inc. on 3.
Valuation
Profitability
| Metric | ATYR | CLRB | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 70.18% |
| Operating margin | (152.19%) | 0.00% | 0.00% |
| Net margin | (155.18%) | 0.00% | 0.00% |
| Free cash flow margin | (148.11%) | 0.00% | 0.00% |
| Return on equity | (93.69%) | (172.99%) | (51.58%) |
| Return on assets | (64.07%) | (116.54%) | (45.91%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack